554451-12-6 Usage
Description
(1S,3R)-Methyl 3-[(tert-butoxycarbonyl)-amino]cyclopentanecarboxylate is a chemical compound with the molecular formula C13H23NO4. It features a cyclopentane ring with a carboxylate group at the C3 position and a tert-butoxycarbonyl (Boc) protected amino group at the C1 position. (1S,3R)-Methyl 3-[(tert-butoxycarbonyl)-amino]cyclopentanecarboxylate is highly valued in organic synthesis due to its versatility and the presence of the Boc protecting group, which allows for selective reactions at other positions in the molecule.
Uses
Used in Pharmaceutical Synthesis:
(1S,3R)-Methyl 3-[(tert-butoxycarbonyl)-amino]cyclopentanecarboxylate is used as a building block or intermediate for the synthesis of various pharmaceuticals. Its unique structure and the Boc protecting group enable the development of complex molecules with specific therapeutic properties.
Used in Agrochemical Production:
In the agrochemical industry, (1S,3R)-Methyl 3-[(tert-butoxycarbonyl)-amino]cyclopentanecarboxylate is utilized as a key intermediate in the production of various agrochemicals. Its ability to be selectively modified and functionalized makes it suitable for creating compounds with targeted effects on pests or crops.
Used in Organic Synthesis:
(1S,3R)-Methyl 3-[(tert-butoxycarbonyl)-amino]cyclopentanecarboxylate is employed as a versatile compound in organic synthesis. The presence of the methyl ester group allows for further functionalization through a range of chemical reactions, making it a valuable component in the creation of diverse organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 554451-12-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,5,4,4,5 and 1 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 554451-12:
(8*5)+(7*5)+(6*4)+(5*4)+(4*5)+(3*1)+(2*1)+(1*2)=146
146 % 10 = 6
So 554451-12-6 is a valid CAS Registry Number.
554451-12-6Relevant articles and documents
NICOTINAMIDE DERIVATIVES
-
Page/Page column 249, (2010/01/12)
The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the trea
NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION
-
Page/Page column 42-43, (2008/06/13)
The present invention relates to novel compounds useful as dipeptidyl peptidase IV (DPP-IV) inhibitors of the formula: (I) wherein Y is -S(O)m, -CH2-, CHF, or -CF2; m is 0, 1, or 2; X is a bond, C1-C5 alkyl (e.g., -CH2-), or -C(=0)-; the dotted line [----] in the carbocyclic ring represents an optional double bond; R1 is substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl, substituted or unsubstituted heteroarylalkyl, CN, -COOR3, CONR3R4, -OR3, -NR3R4, or NR3COR3; R2 is hydrogen, cyano, COOH, or an isostere of a carboxylic acid (such as SO3H, CONOH, B(OH)2, PO3R3R4, SO2NR3R4, tetrazole, -COOR3, -CONR3R4, NR3COR4, or -COOCOR3).
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
-
, (2008/06/13)
The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atheroscler
